Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAMYT.L Regulatory News (AMYT)

  • There is currently no data for AMYT

Directorate Changes

14 Nov 2012 07:00

RNS Number : 0526R
Fastnet Oil & Gas PLC
14 November 2012
 



14 November 2012

Fastnet Oil & Gas plc

Directorate Changes

Fastnet Oil and Gas plc ("Fastnet" or the "Company") (AIM: FAST, ESM: FOI) the E&P company focussed on near term exploration acreage in the Celtic Sea and Africa, is pleased to announce the appointment to the Board of Paul Griffiths as Managing Director. In line with a planned succession process, Paul will be replacing Dr. Stephen Staley who is continuing as a Non-Executive Director, having successfully guided Fastnet through its founding and AIM IPO in June 2012. At the same time, Cathal Friel, previously Non-Executive Chairman, has been appointed Executive Chairman. Both these appointments are effective immediately.

 

Paul Griffiths was appointed Vice President of Exploration at Fastnet in July 2012 with responsibility for establishing the current portfolio of oil and gas assets. He is a graduate in geology from the Royal School of Mines (London) with a proven track record and more than 35 years' experience developing exploration opportunities in NW Europe, North Africa and SE Europe.

 

He worked as an exploration geophysicist and prospect generator for the Libyan National Oil Corporation and Gulf Oil. In 2006 and 2007 he led Island Oil and Gas Plc's drilling campaign in the Celtic Sea offshore Ireland which resulted in four successful gas wells flowing at a combined rate of approximately 54 mm cfgpd.

 

Cathal Friel, Chairman of Fastnet commented:

 

"I would like to thank Stephen for his guidance and diligent hard work in establishing Fastnet and taking it to a position which allows him to hand over day to day management to Paul and look forward to continuing to work with him as a Non-Executive Director.

 

"I am delighted to welcome Paul Griffiths to the Board; Paul has been working with us over a year now and has extensive operational experience in our key licence areas and a network of invaluable industry relationships. He has become an integral part of the team and his ascension to the Board as Managing Director is in line with our planned succession process and in recognition of the role he has played in that time and also the role he has played in helping us secure the two additional Celtic Sea licensing options announced today.

 

"The Board is focussed on aggressively developing Fastnet's exciting portfolio of material prospects to facilitate near term drilling activity to enhance the potential for value creation for our shareholders."

 

Stephen Staley, outgoing CEO of Fastnet, commented:

 

"I am pleased to be able to now hand over the CEO role to Paul and look forward to my continued involvement as a Non-Executive Director of the Company as it develops its portfolio of high impact prospects. I look forward to continuing to work with Paul and the rest of the Fastnet team at this exciting time in the company's growth."

 

For further information, please contact:

 

Fastnet Oil & Gas plc

Cathal Friel, Non-Executive Chairman

Steve Staley, CEO

+353 (1) 644 0007

Shore Capital

(Nominated Adviser & Joint Broker)

Nomad

Bidhi Bhoma

Edward Mansfield

 

Corporate Broking

Jerry Keen

+44 (0) 20 7408 4090

Davy

(ESM Adviser & Joint Broker)

John Frain

Brian Garrahy

Roland French

 

+353 (1) 679 6363

FTI Consulting

Edward Westropp

+44 (0) 207 831 3113

 

Jess Allum

 

Paul Stanard Griffiths (aged 58) currently holds, and has held (including all appointments during the five years preceding the date of this announcement), the following directorships and partnerships, other than of the Company:

 Current Directorships

Petro-Celtex Consultancy Limited

Drillbit Exploration Limited

Pan Maghreb Oil and Gas Limited

Past Directorships

Island Oil & Gas plc

Pathfinder Hydrocarbon Ventures Limited

 

 

There are no other matters which are required to be announced under Rule 17 or Schedule Two paragraph (g) of the AIM rules.

 

Notes to Editors

Fastnet Oil & Gas plc is an independent oil and gas exploration company that focuses on identifying early stage exploration and appraisal opportunities in Offshore Ireland and Africa. It is quoted on the AIM market of the London Stock Exchange and the Enterprise Securities Market (ESM) of the Irish Stock Exchange. Fastnet's aim is to assemble a portfolio of high impact conventional oil and gas assets that will deliver sustainable growth and value for the Company. Its immediate focus is on implementing its Offshore Ireland and Africa strategies where it has been awarded two offshore licensing options in the Celtic Sea (Molly Malone Basin and Mizzen Basin) and acquired a material interest in the highly prospective Foum Assaka permit Offshore Morocco. In addition, Fastnet will continue to pursue new conventional oil and gas opportunities in Africa where the Directors and Advisory Board also have extensive knowledge, contacts and experience of creating value.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ISEDGBDBLSBBGDX
Date   Source Headline
4th Mar 202112:00 pmRNSAmryt Announces Record FY 2020 Results
25th Feb 20217:00 amRNSAmryt Supports Global Rare Disease Day 2021
24th Feb 20217:00 amGNWAmryt to Announce Q4 and FY 2020 Results on Thursday March 4, 2021
10th Feb 20217:00 amRNSAmryt to Present at SVB Leerink Conference
4th Feb 20217:00 amGNWAmryt and Medison Pharma Sign Multi-Regional Distribution Agreements in Canada and Israel
20th Jan 20217:00 amGNWAmryt Receives Reimbursement Approval from NICE for Myalepta® (metreleptin) in England and Wales
6th Jan 20217:00 amRNSAmryt to present at H.C Wainwright Conference
23rd Dec 20207:00 amGNWAmryt Granted Orphan Drug Designation by the FDA for AP103
17th Dec 20207:00 amGNWAmryt Receives Ministry of Health Reimbursement Approval for Lojuxta® (lomitapide) in Saudi Arabia
11th Dec 202010:00 amGNWHolding(s) in Company
9th Dec 20202:45 pmGNWHolding(s) in Company
9th Dec 20207:00 amGNWAmryt Group Receives Marketing Authorisation Approval for Lojuxta® in Brazil
8th Dec 20207:00 amGNWAmryt Announces $40m Private Placement with Leading Biotech Investors
5th Nov 202012:00 pmGNWAmryt Reports Record Q3 2020 Results - Raising FY 2020 Revenue Guidance
29th Oct 20207:00 amGNWAMRYT ANNOUNCES POSITIVE RESULTS FROM PHASE 3 TRIAL OF FILSUVEZ® IN EPIDERMOLYSIS BULLOSA
19th Oct 20207:00 amGNWAmryt and Swixx Sign Distribution Deal for Lojuxta
14th Oct 20207:00 amRNSAMRYT TO ANNOUNCE Q3 RESULTS ON NOVEMBER 5, 2020
14th Oct 20207:00 amGNWNotice of Results
12th Oct 202011:00 amGNWHolding(s) in Company
9th Oct 20207:00 amGNWVirtual Analyst & Investor Event - Tuesday November 3, 2020
8th Oct 20207:00 amGNWAMRYT TO PRESENT EASE TRIAL DATA BY LATE-BREAKING PRESENTATION AT EADV ON OCTOBER 31, 2020
1st Oct 20207:00 amGNWExercise of Options and Total Voting Rights
30th Sep 202012:30 pmGNWHolding(s) in Company
23rd Sep 20207:00 amRNSAMRYT SUPPORTS GLOBAL FH AWARENESS DAY
21st Sep 202011:00 amGNWExercise of Warrants & Issue of Ordinary Shares and Total Voting Rights
15th Sep 20207:00 amRNSPOSITIVE OPINION ON AP103 ORPHAN DRUG DESIGNATION
9th Sep 20202:05 pmRNSSecond Price Monitoring Extn
9th Sep 20202:00 pmRNSPrice Monitoring Extension
9th Sep 20207:00 amRNSPOSITIVE TOP LINE RESULTS FROM PHASE 3 TRIAL IN EB
11th Aug 202011:09 amRNSCANCELLATION OF ADMISSION TO EURONEXT GROWTH
7th Aug 20207:00 amRNSAMRYT PRESENTING AT CANACCORD GENUITY CONFERENCE
6th Aug 202012:00 pmRNSAMRYT ANNOUNCES Q2 2020 RESULTS
29th Jul 20202:30 pmRNSResult of AGM
29th Jul 20207:00 amRNSAMRYT HOSTING KOL CALL ON EB DISEASE LANDSCAPE
20th Jul 20207:00 amRNSAMRYT TO ANNOUNCE Q2 RESULTS ON AUGUST 6, 2020
15th Jul 20208:00 amRNSEuronext Growth Dublin Notice
10th Jul 20207:00 amRNSExercise of Warrants & Issue of Ordinary Shares
8th Jul 20203:09 pmRNSAMRYT LISTED ON NASDAQ & CEO TO RING CLOSING BELL
30th Jun 20207:00 amRNSPOSTING OF ANNUAL REPORT AND NOTICE OF AGM
24th Jun 20207:00 amRNSForm F-1 publicly filed for impending US listing
4th Jun 20202:20 pmRNSDirector/PDMR Shareholding
3rd Jun 202011:30 amRNSDirector/PDMR Shareholding
3rd Jun 20207:00 amRNSAMRYT & SWIXX SIGN DISTRIBUTION DEAL FOR MYALEPTA
11th May 20207:00 amRNSQ1 2020 RESULTS
11th May 20207:00 amRNSFY 2019 RESULTS
7th May 20209:00 amRNSNotice of Results
7th May 20207:00 amRNSFILSUVEZ® CONFIRMED AS GLOBAL BRAND NAME FOR AP101
23rd Apr 20207:00 amRNSEASE CLINICAL STUDY UPDATE
25th Mar 20207:00 amRNSHolding(s) in Company
23rd Mar 20207:00 amRNSMarket Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.